TSNLF (Tristel) Total Operating Expense: $39.90 Mil (TTM As of Dec. 2025)


TSNLF Tristel PLC TSNLF
97 GF Score
Price $5.53
GF Value $6.07
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Tristel Total Operating Expense?

Tristel TSNLF +6.35% 97 Total Operating Expense is $39.90 Mil as of Dec. 2025. GuruFocus rates TSNLF with a GF Score™ of 97/100 and a GF Value™ of $6.07 (Fairly Valued). The stock has 1 warning sign investors should review.

Tristel's Total Operating Expense for the six months ended in Dec. 2025 was $21.09 Mil. Tristel's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was $39.90 Mil.

Tristel Total Operating Expense Related Terms

Tristel Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Tristel's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tristel Total Operating Expense Chart

Tristel Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.02 28.56 28.58 33.84 37.59

Tristel Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.08 16.67 17.50 18.81 21.09
TSNLF
97GF Score
Tristel PLC TSNLF
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tristel Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $39.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $39.90 Mil mean?
Tristel (TSNLF) has a Total Operating Expense of $39.90 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Tristel and its competitors.
Is Tristel's Total Operating Expense too high?
Tristel's current Total Operating Expense is $39.90 Mil. Overall, Tristel has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tristel's Total Operating Expense compare to ISRG and BDX?
Tristel's Total Operating Expense of $39.90 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Tristel and its competitors. Tristel's current Total Operating Expense is $39.90 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tristel stock overvalued right now?
Based on GuruFocus' analysis, Tristel (TSNLF) is currently considered Fairly Valued. The stock's GF Value™ is $6.07, compared to a current price of $5.53 — trading 8.9% below its estimated fair value. The current Total Operating Expense is $39.90 Mil. Tristel's overall GF Score™ is 97/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Tristel (TSNLF), the current Total Operating Expense is $39.90 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tristel (TSNLF) Overvalued in 2026?

Based on GuruFocus' analysis, Tristel stock appears to be undervalued. The current stock price of $5.53 is trading 8.9% below its estimated GF Value™ of $6.07. GuruFocus considers Tristel to be Fairly Valued.

Key valuation signals for TSNLF:

  • Total Operating Expense: $39.90 Mil
  • GF Value™: $6.07 vs. price of $5.53 (8.9% below fair value)
  • GF Score™: 97/100 with 1 warning sign

No single metric tells the full story. See the TSNLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tristel Business Description

Other Exchanges TSTL:UKR1V:Germany
Address Fordham Road, Unit 1B, Lynx Business Park, Newmarket, Snailwell, Cambridgeshire, GBR, CB8 7NY
Tristel PLC's business is the sale to hospitals of its proprietary chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand and for the sporicidal disinfection of environmental surfaces under the Cache brand. Its operating segments include hospital medical device decontamination products used predominantly for infection control in hospitals; the manufacture and sale of hospital environmental surface disinfection products; and pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare. The company generates the majority of its revenue from hospital medical device decontamination and operates geographically in the UK and overseas markets.
97GF Score

Get the complete analysis for TSNLF

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.53
Price
$6.07
GF Value